|
About Primary Immunodeficiency
Treating PID
Subcutaneous Treatment
Subcutaneous administration of immunoglobulin is a method of infusing
antibodies directly into the skin. The immunoglobulin is infused
using a syringe driver, a syringe, and butterfly or thumb needle.
The infusions are usually given into the skin of the abdominal wall,
but sometimes the thigh is used. Although some slight swelling may
occur, infusing immunoglobulin into the skin allows it to spread
throughout the bloodstream faster than when infused intravenously.
Stable Antibody Levels
One advantage of subcutaneous infusions, also called SCIG, is that
very stable antibody levels can be maintained over time. An infusion
on one day will result in slight peak in serum levels after four
days, but the peak will decline slowly. Experience so far with subcutaneous
administration has shown that:
- Subcutaneous administration of immunoglobulins is at least as effective as IVIG in preventing infections,
- Normalised IgG levels are maintained between infusions, and
- There is a low incidence of adverse events.
Home Therapy
SCIG can be performed not only in a hospital or clinic, but also
at home. The infusion technique is easy to learn in the hospital
setting under supervision of a doctor. Once learned, home therapy
is safe for administration and substantially increases patients'
quality of life. With good patient education and continuous support,
SCIG helps patients cope better with the fact that they will require
lifelong therapy.
The majority of patients with primary immunodeficiency disorders
suitable for immunoglobulin replacement therapy generally qualify
for subcutaneous administration and are able to learn the easy infusion
technique.
For further information please click on the link to see the patient
brochure for subcutaneous use.
Subcutaneous
Therapy Brochure [600 KB PDF]
Windows
Media
364 KB
Duration 00:21 |
Quicktime
368 KB
Duration 00:21 |
For further questions
or to see the full video please contact your local Baxter
representative in your country. |
|
You will need Windows
Media Player or QuickTime
Player to view the video.
If you already have one of these
applications, click the video format above.
|
|